SiliconMED Adds Clustered Timeline Visualization Architecture to Haystack: Remote Data Screener
Tuesday, December 18, 2012
Haystack: Remote Data Screener has expanded its real-time search architecture to include timeline visualization across the entire datacenter. This powerful new toolset allows end users to generate thousands of clustered timelines, mixing thousands of data-points from Neuro-Oncology (Any Data Point), Neuro-Pathology (Any Tissue Resource), and Radiology (Any DICOM MR/CT/PET) data sets with just a few clicks.
USC Brain Tumor Center & SiliconMED renew Multi-Year Agreement.
Monday, October 01, 2012
The Brain Tumor Center at USC Hospital / Norris Cancer Center, announced it has awarded SiliconMED a multi-year Medical Informatics contract for Electronic Medical Records, Medical Imaging & Translational Research Application Services.
SiliconMED's initial efforts will focus on the implementation of their ProviderIQ : Electronic Medical Record platform, Translational Research Applications, Diagnostic Medical Imaging & developing their Web Presence. This platform will provide a foundation for the Neuro-Oncology's Translational Research and Clinical Operations.
UCLA Medical Center & SiliconMED extend partnership for 13th consecutive year.
Friday, August 17, 2012
The Neuro-Oncology Program at UCLA Medical Center and SiliconMED have extended their partnership for a 13th consecutive year.
During the coming year SiliconMED will continue to help drive practice growth and manage overall IT operations, while developing next generation tools to help leverage emerging bio-marker and on campus MGMT Methylation datasets. "SiliconMED brings our program a world class infrastructure and software tools that continue to scale to meet the demands of our patients, research teams and institution commitments. In the end their tools speed the decision making process for us at all levels. Enabling us to focus on treating patients, and leaving the software development and IT infrastructure to SiliconMED.", Timothy Cloughesy M.D.
"UCLA is a valuable partner as they are constantly pressing us for the next big thing. Dr. Cloughesy and his group keep us sharp, helping us to focused squarely on the brain tumor community. Ensuring we continue to build tools that will have the greatest impact in the clinical and research setting.", Michael Quinn, CEO SiliconMED. "Their passion to create better treatment options for their patients is unmatched.